RenovoRx Inc
Stock Chart, Company Information, and Scan Results
$1.26(as of Aug 13, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
RenovoRx Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$1.26
Ticker SymbolRNXT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees17
CountyUSA
Market Cap$50.5M
EBIDTA-12.4M
P/E Ratio0.00
Forward P/E Ratio0.00
Earnings per Share-0.33
Profit Margin0.00%
RSI73.00
Shares Outstanding45.1M
ATR0.08
52-Week High1.45
Volume991,906
52-Week Low0.70
Book Value0.0M
P/B Ratio0.00
Upper Keltner1.17
P/S Ratio0.00
Lower Keltner0.83
Next Earnings DateUnknown
Cash Surplus0.0M
Next Ex-Dividend DateUnknown
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
RenovoRx Inc In Our Stock Scanner
As of Aug 13, 2026
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.